|
PTPRK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00379999978806E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.32219999685546E-08 |
| Normal-vs-Stage2 |
1.534440E-01 |
| Normal-vs-Stage3 |
6.982500E-04 |
| Normal-vs-Stage4 |
2.336100E-03 |
| Stage1-vs-Stage2 |
5.825900E-02 |
| Stage1-vs-Stage3 |
4.990400E-01 |
| Stage1-vs-Stage4 |
5.501400E-01 |
| Stage2-vs-Stage3 |
2.191600E-01 |
| Stage2-vs-Stage4 |
2.326200E-01 |
| Stage3-vs-Stage4 |
9.495600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66150000424636E-08 |
| Normal-vs-AfricanAmerican |
1.097510E-02 |
| Normal-vs-Asian |
4.644400E-03 |
| Caucasian-vs-AfricanAmerican |
9.188200E-01 |
| Caucasian-vs-Asian |
5.575400E-01 |
| AfricanAmerican-vs-Asian |
6.091800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.592390E-04 |
| Normal-vs-Female |
1.73520000035232E-07 |
| Male-vs-Female |
6.145800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66389999556316E-08 |
| Normal-vs-Age(41-60Yrs) |
1.200120E-04 |
| Normal-vs-Age(61-80Yrs) |
2.340100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.909800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.363900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.447610E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.224200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.544400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.179200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.516600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.627000E-01 |
| Classical-VS-Follicular |
1.66533453693773E-14 |
| Classical-VS-Other |
3.052800E-01 |
| Classical-VS-Normal |
5.45230527393414E-11 |
| Tall-VS-Follicular |
1.993890E-04 |
| Tall-VS-Other |
2.684200E-01 |
| Tall-VS-Normal |
1.015320E-03 |
| Follicular-VS-Other |
1.531830E-01 |
| Follicular-VS-Normal |
2.471400E-01 |
| Other-VS-Normal |
4.695000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.521090E-03 |
| Normal-vs-N1 |
1.720230E-03 |
| N0-vs-N1 |
1.977020E-01 |
|
|
